May 26, 2017 / 12:41 PM / 5 months ago

BRIEF-Trillium announces pricing of U.S.$30.0 mln public offering of common shares

May 26 (Reuters) - Trillium Therapeutics Inc:

* Trillium announces pricing of U.S.$30.0 million public offering of common shares and series II non-voting convertible first preference shares

* Trillium Therapeutics Inc - priced its public offering of 2.8 million common shares and 3.3 million series II non-voting convertible first preferred shares

* Trillium Therapeutics Inc - common shares are being sold at a public offering price of U.S.$5.00 per share

* Trillium Therapeutics Inc - series II non-voting convertible first preferred shares are being sold at a public offering price of U.S.$5.00 per share Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below